🆕 ACC/AHA/Multisociety Guideline for the Evaluation & Management of Acute PE in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management & follow‑up of adults with acute PE. https://bit.ly/4aE5gmi #JACC #CardioSky #ClinicalGuidelines

A traditional Chinese mind-body practice that combines slow, structured movement, deep breathing & meditative focus lowered BP as effectively as brisk walking, in a large RCT published in #JACC. BP reductions were seen after 3 months & sustained for 1 year. https://bit.ly/4kKQrDh #CardioSky

Ex-vivo study of 23 to 34 mm Evolut THVs: IFU-guided post-dilation preserved frame geometry and leaflet integrity. Oversized balloons caused waist over-expansion and immediate leaflet tears. https://bit.ly/4qHkFZ1 #JACCINT #CardioSky

6 yrs after surgery or #TAVR with CoreValve/Evolut, low-risk AS pts showed no difference in all-cause mortality or disabling #stroke in the Evolut Low-Risk trial. However, reinterventions were higher after TAVR, largely driven by increased AR. https://bit.ly/4csz87C #JACC #vhdAS #SAVR #CardioSky

Legislative mandates for universal #ECG screening in competitive athletes pose potential harm & unintended consequences, drawing attention & resources away from EAP implementation, an effective intervention for saving athletes' lives. https://bit.ly/4axLadx #JACC #SportsCardio #CardioSky

Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses www.jacc.org/doi/epdf/10.... @jaccjournals.bsky.social #cardiosky

In #JACC, diet quality was more strongly associated w/ #CHD risk than macronutrient quantity. High-quality low-carb & low-fat patterns were linked to lower risk, while versions high in refined carbs & animal products were associated w/ higher CHD risk. https://bit.ly/4qrwFhj #HFWeek2026 #CardioSky

Next-gen Amulet 360 #LAAO showed favorable early outcomes in the VERITAS study. Both primary endpoints were met, and key clinical outcome rates were low. No leak was observed in 93.9% of patients on the 45-day TEE. https://bit.ly/4a1rS10 #JACCCEP #AFib #CardioSky #AFSymposium2026

ADVANTAGE AF subanalysis: Linear bipolar PFA for CTI shows safety and efficacy comparable to RF, with greater efficiency, and supports a standardized coronary safety protocol. Details in #JACC: https://bit.ly/4rm47al #AFSymposium2026 #AFib #CardioSky

🔔 Call for Papers from #JACCINT! Celebrating 10 years of valve leaflet modification, we're seeking original research & cases on outcomes, imaging, devices, & emerging applications, from LAMPOON & BASILICA to what’s next. 🗓️ Submit by March 9, 2026 🔗 https://bit.ly/4rzqt7U #CardioSky #CathLab

New season of #JACC This Week 🎙️ Dr. @hmkyale.bsky.social#JACC& co-host Dr. Carolyn Lam kick off a refreshed, more conversational era of the podcast, reflecting on the show’s evolution, & this week's issue on VHD Listen & subscribe: https://podcasts.apple.com/us/podcast/jacc-this-week/id932118437

Recreational drug use is a strong, independent predictor of worse one-year cardiovascular outcomes in patients with #cvACS, significantly in those with #STEMI, according to results from the ADDICT-ICCU study published in #JACCAdvances. Get the details: https://bit.ly/3LYR4fr #CardioSky

Smart devices have a pooled AUC of 0.97 for detecting AFib, which sounds great, but specificity ranging from 79-99% still leaves plenty of room for false positives www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social #cardiosky

Our brief report now online in @jaccjournals.bsky.social (JACC: Advances) investigates trends 📉 in mortality from #CVD & screenable cancers in the US, highlighting the need to enhance current screening practices & manage 💔 disease risk factors www.jacc.org/doi/10.1016/...

ESC, ACC, AHA & World Heart Federation have released their first joint statement on environmental stressors and #CVD, outlining 6 priority areas and calling for stronger air/noise standards, fossil fuel phaseout & toxic chemical regulation. Get the details: https://bit.ly/3LoJ1bD #JACC #CardioSky

ACC published its inaugural #JACC Cardiovascular Statistics report. The document highlights the prevalence of major #CVD risk factors, #HealthDisparities, and trends in quality of care. Find out more with @gohealio.bsky.social#JACC#CVD#HealthDisparitiesttps://bit.ly/4jDKJ5e #JACCStats

🚨 Dinesh Kalra, MD, FACC, has been selected as the incoming editor-in-chief of #JACCAdvances. An award-winning educator & ACC leader, he plans to expand the journal’s scope & enhance digital engagement and author experience. Please join us in welcoming him! 👏👏 #CardioSky @dineshkalra.bsky.social#JACCAdvances

🆕 #JACC CV statistics report highlights progress, ongoing challenges, & opportunities to improve CV health in the US. From rising obesity & diabetes to stalled BP control & widening disparities, the data offer a roadmap for action. Read the full report: https://bit.ly/3N8HCX9 #JACCStats #CardioSky

The new year is underway—now’s the time to stay connected to what’s shaping cardiovascular care in 2026. #JACC delivers research, guidelines, and expert insights straight to your inbox. Subscribe to JACC email alerts and start the year informed: https://bit.ly/4pCcAF8

The new 2026 ACC/AHA/Multisociety Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease (PAD) provide a comprehensive framework for assessing and improving PAD care across various clinical settings. Get the details in #JACC: https://bit.ly/45xtCMK #cvPAD #CardioSky

New JACC issue centers on cardiovascular care for older adults: • Frailty and BP control • Frailty as a prognostic tool in HF • Loss of Y chromosome and CV risk • Vascular cognitive impairment and dementia Age is not the whole story. 👉 JACC.org @jaccjournals.bsky.social

As we close out 2025, thank you to our editorial board members, authors, reviewers, staff, & readers for advancing CV science and care. In 2026, #JACCJournals will continue elevating impactful research & improving patient outcomes 🌎 Here’s to a new year of advancing heart health together! 🫀🎆

Among patient with echo showing severe aortic stenosis, 74.3% of men had it in their problem list, compared to 64.1% for women. www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social #cardiosky

#ACCMember Sections were responsible for 16 #JACC publications in 2025. 📚 Learn more about how the Sections are making an impact and get involved: https://bit.ly/3KBA4va #CardioSky #MedSky @jaccjournals.bsky.social

Stay ahead of what’s shaping cardiovascular care in 2026. #JACC, the ACC’s flagship journal, delivers cutting-edge research, clinical guidelines, and expert perspectives—straight to your inbox. Subscribe to FREE JACC email alerts and stay informed: https://bit.ly/4pCcAF8 #CardioSky

❄️ Happy Holidays to the #JACCJournals editorial board members, authors, reviewers, staff, and readers and best wishes for a successful and healthy 2026 ahead! ❤️🩺

📈 Looking back at 2025 with #JACCCardioOnc! Explore our interactive Year in Review to see the journal’s global reach, latest impact factor, and most read & downloaded articles. Discover the research shaping #CardioOnc today: https://bit.ly/4p6wV4k #CardioSky #MedSky

Los Angeles residents saw significant rises in cardiopulmonary illness in the 3 months after the Jan 2025 Eaton & Palisades wildfires, per a study in #JACC. Findings are based on Cedars-Sinai ED data compared with the same period in 2018–2024. https://bit.ly/3YCJUjv #CardioSky

2025 ACC/AHA/Multisociety #ClinicalGuideline on #ACHD highlights practice-changing recommendations for caring for a diverse ACHD population. Explore the Guideline-at-a-Glance in #JACC to accelerate adoption in practice: https://bit.ly/4pRFGAE #CardioSky

The ACC & AHA, along with several other leading medical associations, have issued a new guideline for #ACHD, updating recommendations for monitoring, counseling, & treatment based on 2017–2024 evidence & replacing the 2018 guidance Get the details in #JACC: https://bit.ly/3Y4KM0d #CardioSky

With the US FDA approving a growing number of products that can perform quantitative coronary plaque analysis (QCPA), a new ACC Scientific Statement provides consensus recommendations on the appropriate use of QCPA in clinical practice Get the details in #JACCIMG: https://bit.ly/3MRSd8x #CardioSky

New ACC Scientific Statement on the management of PAD in adults w/ #diabetes adds context to the 2024 ACC/AHA Lower Extremity PAD Guideline & "emphasizes a modern, evidence-based approach to care" starting w/ screening & advancing through treatment. https://bit.ly/4596FiD #JACC #CardioSky #cvPAD

Modern cancer therapies heighten the importance of managing CV treatment-related complications. A new @accintouch.bsky.social CCG report outlines best practices for diagnosing & managing CV adverse effects from Bruton’s TKIs, ICIs & VEGF inhibitors https://bit.ly/4iYlLxq #JACC #CardioOnc #CardioSky

🚨 #ACC26 hits New Orleans Mar 28–30! Boost your research by publishing with #JACCJournals. 🗓️ Deadlines: • Jan 23 – oral/poster • Feb 15 – late-breakers Why #JACC? ⭐ Top-tier impact 🌍 Global reach ⚡ Easy submissions 📝 Preprint-friendly Submit today 🔗 https://bit.ly/3KKcHPU #CardioSky

Simplifying nutrition info can help consumers make healthier choices and lower #CVD risk, per new ACC guidance in #JACC. The guidance backs a standardized front-of-pack label highlighting key nutrients to limit or encourage. Get the details: https://bit.ly/4pMXfkK #CardioSky

DEADLINE EXTENDED! 🏀 #JACCCaseReports + #ACCSportsCardio are teaming up for a 2026 Sports Cardiology themed issue during March Madness & #ACC26. 🔗 Learn more & submit: https://www.jacc.org/call-for-papers/case-reports?utm_medium=social&utm_source=social_post&utm_campaign=social_post #SportsCardio

Finish the year strong with our final #JACCJournals Club! Earn last-minute CME as Caio De Assis Moura Tavares, MD, and Pedro A. Lemos, MD, PhD, break down key insights from their NEO-MINDSET substudy and what it means for the field. Save your spot: https://bit.ly/4pDq2YY #CardioSky #MedSky #AHA25

📸 JACC Journals were honored to join QICC 2025 in Hangzhou, China last week where leaders, including JACC Editor-in-Chief Dr. Harlan Krumholz, gathered to bridge global innovation in cardiovascular science. 🫀 Get the science published in #JACC here: https://bit.ly/48c9EHX #CardioSky #JACCJournals

The latest update from the #GBDStudy not only reveals the current state of #CVD on a global scale, but also points to the interventions that can help accelerate progress. This week's #JACC focus issue reflects on how these findings can guide the future of CV care. https://bit.ly/47Z4Nep #CardioSky

New HRS/ACC scientific statement outlines guiding principles for performing intracardiac ablation procedures in ASCs, highlighting their growing role, evidence for safe use in select patients, & key regulatory & operational standards. https://bit.ly/4psqysT #CardioSky #JACC #epAblation

#JACCJournals is honored to join QICC 2025, a leading global forum for CV science & innovation. Browse late-breaking trials, real-world insights, hands-on sessions & global collaboration shaping heart care’s future ❤️‍🩹🌏 https://bit.ly/48c9EHX #JACC #JACCINT #JACCCaseReports #CardioSky

86 families w/ hereditary #ATTR, cascade genetic screening identified a median of 2 carriers per proband, enabling earlier Dx & Tx. 1/3 of at-risk relatives were untested, showing the need to improve family screening. https://bit.ly/4paOdOs #amyloidosis #JACCCardioOnc #CardioOnc #CardioSky

New multi-society Advanced Training Statement on Advanced #cvImaging addresses the core competencies & training requirements necessary for advanced CV imagers across all 4 imaging modalities – echocardiography, CCT, nuclear cardiology & #CMR. Get the details: https://bit.ly/3M87z8p #JACC #CardioSky

Visceral fat is the hidden driver linking CKD and HFpEF. This Special Communication reframes adiposity as a pathogenic organ fueling renal and cardiac decline. #HFpEF #CKD More in the newest issue of #JACC: https://bit.ly/43ioRpq #CardioSky

Semaglutide works no matter your sex. In STRIDE, weekly 1.0 mg semaglutide improved walking function in PAD + T2D across men and women. But baseline differences show why sex-specific analysis still matters. Read more in new issue of #JACC: https://bit.ly/4fWwsik #CardioSky #GLP1

🫀 New ACC scientific statement in #JACC: Obesity drives risk for HF, CAD & #stroke, but targeted weight loss can change the game. Semaglutide & tirzepatide show promise in #HFpEF, but challenges remain. 🔗 Read the whole statement here: https://bit.ly/43qdfRg @accintouch.bsky.social#JACC#stroke#HFpEF#CardioSky

Current NT-proBNP thresholds miss high-BMI patients at risk. In pooled #HFpEF trials, those w/ severe obesity faced over twice the event rate despite “normal” values. It’s time to personalize BNP cutoffs. ⚖️ Explore more in the new issue of #JACC: https://bit.ly/3Lp3JaX #CardioSky

📊 New meta-analysis in #JACC: GLP-1 RAs reduced CV death, MACE & HF risk across 99K+ patients. ✅ Consistent benefits across diabetes, obesity, CKD & HF ⚠️ ↑ GI & gallbladder events 🎯 Personalize therapy by patient profile Read more in the new issue: https://bit.ly/4oHwWwn #CardioSky

Heart and liver, one metabolic disease. MASLD fuels cardiovascular risk through inflammation, insulin resistance and fat toxicity. Time for cardiologists to lead in diagnosis and prevention. More in the new issue of #JACC: https://bit.ly/3XiYxrB #cvMetabolic #cvPrev #CardioSky

🗨️ "Packer et al. advance a bold & thought-provoking thesis: that visceral adiposity, not hyperglycemia, is the dominant modifiable driver linking type 2 diabetes to HFpEF." -Drs. Krumholz & Inzucchi Read the entire Viewpoint in the newest issue of #JACC: https://bit.ly/4hSh0og #CardioSky